Related Experiment Video
Updated: Sep 12, 2025

06:52
Kinetic Screening of Nuclease Activity using Nucleic Acid Probes
Published on: November 1, 2019
8.4K
SHAPE-based chemical probes for studying preQ1-RNA interactions in living bacteria
José A Reyes Franceschi1, Emilio L Cárdenas2, Brandon J C Klein2
1Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan 48109, United States.
Biorxiv : the Preprint Server for Biology
|August 8, 2025
Summary
Researchers developed a new chemical probe to identify RNA-small molecule interactions within cells. This method helps map binding sites, crucial for advancing RNA-targeted drug discovery and ensuring on-target activity.
Area of Science:
- Chemical biology
- RNA biology
- Drug discovery
Background:
- Interrogating RNA-small molecule interactions is vital for RNA-targeted drug discovery.
- Identifying small molecule-bound RNAs and their binding sites in cells is essential for hit-to-lead campaigns.
Purpose of the Study:
- To develop a chemical probing strategy to identify and map RNA-small molecule interactions within living cells.
- To demonstrate the utility of this strategy using the preQ1 metabolite and its riboswitch RNA as a model system.
Main Methods:
- Development of an in vivo click selective 2'-hydroxyl acylation analyzed by primer extension (icSHAPE)-based probe.
- Utilizing the probe in a preQ1 riboswitch reporter assay to confirm biological activity.
- Enriching the preQ1 riboswitch from bacterial cells using the developed probe.
- Mapping the preQ1 binding site on the riboswitch RNA using mutational profiling (MaP).
Main Results:
- The developed icSHAPE-based preQ1 probe demonstrated biological activity in a reporter assay.
- The probe successfully enriched the target preQ1 riboswitch from living bacterial cells.
- The preQ1 binding site on the riboswitch RNA was successfully mapped using mutational profiling.
Conclusions:
- This chemical probing strategy enables the interrogation of cellular RNA-small molecule interactions.
- The method supports the development of RNA-targeted therapeutics by identifying on-target activity.
- This approach fills a technological gap in studying RNA-small molecule interactions in complex cellular environments.

